View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program
The COVID-19 pandemic has hurt 340B covered entities due to Medicare Part B reimbursement cuts and drug manufacturer actions that limit access to 340B pricing.
The good news is that members of Congress continue to protect the 340B program thanks to strong grassroots actions by 340B advocacy groups and continued bipartisan support.
Join us for our fifth Omnicell Live “View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program,” where 340B industry insider Ted Slafsky and Omnicell 340B leaders will discuss the latest industry developments and the status of proposed legislative actions.
We’ll also bring the covered entity’s perspective to the conversation as we discuss strategies for optimizing program performance amidst the ever-changing 340B landscape.
Senior Director, Sales and Account Management, Omnicell 340B
Jeff Spencer is an experienced leader and consultant in the healthcare industry, with special expertise in relationship management, 340B drug programs and health system pharmacy strategies. Throughout his career, Jeff has helped a diverse range of clients successfully develop and implement 340B programs that improve cost-effectiveness, operational efficiency and patient health outcomes. In his role with Omnicell 340B, Jeff is responsible for sales, client growth and satisfaction. Prior to his 11 years with PSG as a consultant and 340B Link leader, he worked for six years in the health and group benefits consulting area with Towers Watson
Publisher and CEO of 340B Report
Ted Slafsky is the Publisher and CEO of 340B Report, the first and only independent news service covering the federal 340B drug pricing program. He is also Founder and Principal of Wexford Solutions, a Washington, DC based firm that provides government relations, communications, and business development services. Ted has close ties to Congress, the hospital C-Suite and other decision makers, which gives him early access to premiere industry news. Ted's industry experience includes a 22 year leadership role with 340B Health. He was previously a journalist at U.S. News & World Report.
Co-Founder & Managing Partner, The Alinea Group, LLC
Shrujal Patel is a co-founder of The Alinea Group and the Managing Partner of the Chicago Office. Shrujal is a 340B subject matter expert and was formerly a key thought leader in Navigant Consulting’s 340B practice. He has assisted several top ranked University Health Systems and Hospitals, Children’s Hospitals, Federal grantees, and Community hospitals with implementing and optimizing their 340B program, as well as establishing and executing 340B audits and compliance protocols. Shrujal has spent the last 20 years utilizing his expertise to assist healthcare, life science, and capital investment firms to maximize revenue and investment returns, reduce costs, and optimize operations.
340B Coordinator, New Hanover Regional Medical Center
Melissa Romero is the 340B Coordinator for New Hanover Regional Medical Center, a 855 bed DSH hospital in Wilmington, NC. She has over 10 years of hospital pharmacy experience including time as a pharmacy buyer. Melissa is responsible for overseeing 340B compliance, audits, and operations at the organizational level.